Back
Actinium Pharmaceuticals Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
25
ATNM
Actinium Pharmaceuticals
Last Price:
1.80
Seasonality Move:
-4.37%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
54.41
Seasonality Move:
7.55%
Sell
25
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $1.80. The Score for ATNM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ATNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $1.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $54.43
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
ATNM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 33.69 | Sell |
Chaikin Money Flow: | -79708 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.78 - 1.96) | Sell |
Bollinger Bands (100): | (2.62 - 8.56) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.8 | Buy |
Relative Strength Index (14 RSI): | 43.18 | Sell |
Chaikin Money Flow: | -435004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ATNM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.81 | Sell |
20-day SMA: | 1.84 | Sell |
50-day SMA: | 3.13 | Sell |
200-day SMA: | 6.14 | Sell |
8-day EMA: | 1.81 | Sell |
20-day EMA: | 1.96 | Sell |
50-day EMA: | 3.08 | Sell |
200-day EMA: | 5.58 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.08 | Sell |
20-day SMA: | 56.96 | Sell |
50-day SMA: | 52.99 | Buy |
200-day SMA: | 46.88 | Buy |
8-day EMA: | 56.5 | Sell |
20-day EMA: | 56.46 | Sell |
50-day EMA: | 53.4 | Buy |
200-day EMA: | 47.32 | Buy |
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.09 per share, an increase this year of $0.62 per share, and an increase next year of $0.66 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Actinium Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |